Panel-Based Exome Sequencing for Neuromuscular Disorders as a Diagnostic Service
Dineke Westra(Radboud University Nijmegen), Nicol C. Voermans(Radboud University Nijmegen), Benno Küsters(Radboud University Nijmegen), Brian Hon‐Yin Chung(Long Island Jewish Medical Center), H.S. Chan(Chinese University of Hong Kong), Corrie E. Erasmus(Radboud University Medical Center), Amanda Krause(National Health Laboratory Service), Marjolein Kriek(Leiden University), Erica H. Gerkes(University Medical Center Groningen), Christian Gillissen(Radboud University Nijmegen), Nanna Witting(University of Copenhagen), Paul A. van der Zwaag(University Medical Center Groningen), Meyke Schouten(Radboud University Nijmegen), Corien C. Verschuuren‐Bemelmans(University Medical Center Groningen), Anneke J. van der Kooi(Amsterdam UMC Location University of Amsterdam), Suzanne C.E.H. Sallevelt(Maastricht University), Anneke J.A. Kievit(Erasmus MC), Christine de Die‐Smulders(Maastricht University Medical Centre), Bas C. Stunnenberg(Radboud University Nijmegen), Christa de Geus, Baziel G.M. van Engelen(Radboud University Nijmegen), Christiaan G. J. Saris(University Medical Center Utrecht), Karin van Spaendonck‐Zwarts(Amsterdam UMC Location University of Amsterdam), Yves Sznajer, Daniela Q.C.M. Barge‐Schaapveld(Leiden University), Maartje Pennings(Radboud University Nijmegen), Isabelle Maystadt(Institute of Pathology and Genetics), Ingrid P.C. Krapels(Maastricht University Medical Centre), Saskia Bulk(University Medical Center Utrecht), Erik‐Jan Kamsteeg(Radboud University Nijmegen), Rowdy Meijer(Radboud University Nijmegen), Bitten Schönewolf‐Greulich(Rigshospitalet), Magnhild Rasmussen(Oslo University Hospital)
Cited by 50
Related Papers
Rare coding variation provides insight into the genetic architecture and phenotypic context of autism
|Nature Genetics|2022|613
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology
|Nature Genetics|2021|567
Risk Factors for Malignant Ventricular Arrhythmias in Lamin A/C Mutation Carriers
|Journal of the American College of Cardiology|2012|519
A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study
|The Lancet|2023|508
High Rate of Recurrent De Novo Mutations in Developmental and Epileptic Encephalopathies
|The American Journal of Human Genetics|2017|456